MetaVia Inc (MTVA) concluded trading on Wednesday at a closing price of $0.88, with 6.13 million shares of worth about $5.39 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -60.56% during that period and on May 21, 2025 the price saw a gain of about 26.79%. Currently the company’s common shares owned by public are about 8.65M shares, out of which, 7.11M shares are available for trading.
Stock saw a price change of 31.26% in past 5 days and over the past one month there was a price change of 16.73%. Year-to-date (YTD), MTVA shares are showing a performance of -56.87% which decreased to -81.21% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.65 but also hit the highest price of $5.30 during that period. The average intraday trading volume for MetaVia Inc shares is 643.49K. The stock is currently trading 18.16% above its 20-day simple moving average (SMA20), while that difference is down -21.93% for SMA50 and it goes to -60.03% lower than SMA200.
MetaVia Inc (NASDAQ: MTVA) currently have 8.65M outstanding shares and institutions hold larger chunk of about 3.64% of that.
The stock has a current market capitalization of $17.13M and its 3Y-monthly beta is at 0.27. It has posted earnings per share of -$3.36 in the same period. It has Quick Ratio of 1.55 while making debt-to-equity ratio of 0.03. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for MTVA, volatility over the week remained 8.11% while standing at 8.37% over the month.
Stock’s fiscal year EPS is expected to rise by 61.17% while it is estimated to increase by 2.71% in next year. EPS is likely to shrink at an annualized rate of 22.53% for next 5-years, compared to annual growth of 67.49% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by H.C. Wainwright on December 30, 2024 offering a Buy rating for the stock and assigned a target price of $12 to it.
